Article Versions Notes

Alonzi T, Aiello A, Petrone L, Najafi Fard S, D’Eletto M, Falasca L, Nardacci R, Rossin F, Delogu G, Castilletti C, et al. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy. Cells. 2022; 11(1):52. https://doi.org/10.3390/cells11010052

Alonzi, Tonino, Alessandra Aiello, Linda Petrone, Saeid Najafi Fard, Manuela D’Eletto, Laura Falasca, Roberta Nardacci, Federica Rossin, Giovanni Delogu, Concetta Castilletti, and et al. 2022. "Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy" Cells 11, no. 1: 52. https://doi.org/10.3390/cells11010052

Alonzi, T., Aiello, A., Petrone, L., Najafi Fard, S., D’Eletto, M., Falasca, L., Nardacci, R., Rossin, F., Delogu, G., Castilletti, C., Capobianchi, M. R., Ippolito, G., Piacentini, M., & Goletti, D. (2022). Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy. Cells, 11(1), 52. https://doi.org/10.3390/cells11010052